1. Home
  2. JAZZ vs MIDD Comparison

JAZZ vs MIDD Comparison

Compare JAZZ & MIDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAZZ
  • MIDD
  • Stock Information
  • Founded
  • JAZZ 2003
  • MIDD 1888
  • Country
  • JAZZ Ireland
  • MIDD United States
  • Employees
  • JAZZ N/A
  • MIDD N/A
  • Industry
  • JAZZ Biotechnology: Pharmaceutical Preparations
  • MIDD Industrial Machinery/Components
  • Sector
  • JAZZ Health Care
  • MIDD Industrials
  • Exchange
  • JAZZ Nasdaq
  • MIDD Nasdaq
  • Market Cap
  • JAZZ 6.5B
  • MIDD 7.5B
  • IPO Year
  • JAZZ 2007
  • MIDD N/A
  • Fundamental
  • Price
  • JAZZ $122.38
  • MIDD $135.78
  • Analyst Decision
  • JAZZ Buy
  • MIDD Buy
  • Analyst Count
  • JAZZ 14
  • MIDD 7
  • Target Price
  • JAZZ $173.57
  • MIDD $158.00
  • AVG Volume (30 Days)
  • JAZZ 613.8K
  • MIDD 670.2K
  • Earning Date
  • JAZZ 11-06-2024
  • MIDD 10-31-2024
  • Dividend Yield
  • JAZZ N/A
  • MIDD N/A
  • EPS Growth
  • JAZZ 458.10
  • MIDD N/A
  • EPS
  • JAZZ 7.04
  • MIDD 7.26
  • Revenue
  • JAZZ $3,992,712,000.00
  • MIDD $3,869,857,000.00
  • Revenue This Year
  • JAZZ $7.43
  • MIDD N/A
  • Revenue Next Year
  • JAZZ $6.39
  • MIDD $3.46
  • P/E Ratio
  • JAZZ $17.64
  • MIDD $19.02
  • Revenue Growth
  • JAZZ 5.23
  • MIDD N/A
  • 52 Week Low
  • JAZZ $99.06
  • MIDD $118.41
  • 52 Week High
  • JAZZ $134.17
  • MIDD $161.01
  • Technical
  • Relative Strength Index (RSI)
  • JAZZ 59.35
  • MIDD 47.50
  • Support Level
  • JAZZ $108.74
  • MIDD $125.95
  • Resistance Level
  • JAZZ $128.99
  • MIDD $138.90
  • Average True Range (ATR)
  • JAZZ 2.93
  • MIDD 3.52
  • MACD
  • JAZZ 1.13
  • MIDD -0.17
  • Stochastic Oscillator
  • JAZZ 62.86
  • MIDD 56.05

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

About MIDD Middleby Corporation (The)

The Middleby Corp is engaged in designing, manufacturing, marketing, distribution and service of a broad line of foodservice equipment used in all types of commercial restaurants and institutional kitchens, food preparation, cooking, baking, chilling and packaging equipment for food processing operations, and premium kitchen equipment including ranges, ovens, refrigerators, ventilation, dishwashers and outdoor cooking equipment used in the residential market. The company conducts its business through three principal business segments namely the Commercial Foodservice Equipment Group, the Food Processing Equipment Group and the Residential Kitchen Equipment Group. The firm derives majority revenue from Commercial Foodservice Equipment Group segment.

Share on Social Networks: